Experience

Cima Universidad de Navarra

• Spain
• Research Services
• 100 - 200 Employee

• Head of the Atherothrombosis Laboratory

  • Feb 2015 - Present

• Researcher of the Cardiovascular Diseases Program

  • Feb 2002 - Present



Hemostatics

• Spain
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Scientific Officer

  • Aug 2020 - Present

  Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions. Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases). Hemostatics is developing a novel antifibrinolytic agent to reduce bleeding in life-threatening and disabling haemorrhagic conditions. Thanks to an innovative mechanism of action to inhibit fibrinolysis, our patented preclinical candidate is aiming to address a number of significant unmet medical needs in trauma, surgery, ICH, PPH, GI bleeding and in several bleeding disorders (Rare Diseases).



University of Navarra

• Spain
• Education Management
• 700 & Above Employee

• Invited Professor - Master in Biomedical Translational Research

  • Sep 2009 - Present